
17 March 2026 - Patients in England are set to receive some new medicines 3 to 6 months earlier under a streamlined approval process being launched by the MHRA and NICE.
A new aligned pathway between the Medicines and Healthcare products Regulatory Agency (MHRA) and NICE, along with an improved advice service, will help bring medicines to patients faster and give companies greater certainty in planning.